This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:
878592-87-1
Purity:
99.36
Molecular Weight:
419.42
Alternative Names:
JNJ-Q2
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Avarofloxacin (JNJ-Q2) is a broad-spectrum fluoroquinolone antibacterial agent being developed for the treatment of acute bacterial skin and skin-structure infections and community-acquired pneumonia[1]. Avarofloxacin (JNJ-Q2) is an aminoethylidenylpiperidine fluoroquinolone that demonstrates antibacterial effect against numerous Gram-positive bacteria with a mean 0.12 mg/L MIC90 value[2]. Avarofloxacin (JNJ-Q2) has potential for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections[3].
Storage Temperature:
-20°C, 3 years; 4°C, 2 years (Powder)